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et al.: Andrea DelMastro

On the Job

Changing Lives Through Research

Clinical Studies Target Fewer Complications,
Better Outcomes for Vascular Surgery
Two studies at the Jefferson
Vascular Center (JVC) are assessing
innovative methods to reduce risk of
complications — and increase positive
outcomes — for vascular surgery
patients. Here, Paul DiMuzio, MD,
FACS, William M. Measey Professor
of Surgery and Co-Director, Jefferson
Vascular Center, reviews what both
studies mean for patient care.

Andrea DelMastro

‘Game-changer’ for groin wounds
As Dr. DiMuzio explains, groin incisions
in vascular surgery are a source of
significant morbidity and healthcare
costs. When groin wounds become
infected, patients may have to be
readmitted and undergo additional
surgery. Some patients are at greater
risk because of diabetes and obesity,
others because of the surgical
technique required for their treatment.
In exploring ways to decrease groin
wound infections in high-risk patients,
the JVC identified a possible solution
in PrevenaTM — a sponge covered
in adhesive that attaches to a small
suction device. The suction device
removes fluids from the region,
helping reduce the risk of infection.
Already FDA-approved, Prevena is
used by cardiac surgeons for sternal
incisions and by orthopedic surgeons
in total joint replacements.
“No one had conducted a prospective
randomized trial to determine if
Prevena is a viable option for highrisk groin wounds,” he says. “We
were the first.”
The results of Jefferson’s two-year
study — which will be presented
later this Spring at the 2017 Annual
Meeting of the Society for Vascular
Surgery in San Diego — showed a
significant reduction in infections
and re-admissions. Hospital costs
declined by an average of $6,000
per patient.

We are now using [the
Prevena] device for every
patient with high-risk
groin incisions, and
we expect it to become
a standard of care
everywhere once the
findings are published.

The Jefferson Vascular Center surgeons, Drs. Paul DiMuzio, Dawn Salvatore and Babak Abai, rely on the support of
advanced practice nurses Meghan McCullough, MSN, RN, FNP, AGACNP, and Cara Staley, MSN, RN-BC, AGACNP-BC
(on either side of Dr. Salvatore) to manage the Prevena and ROADSTER 2 clinical trials.

“We are now using this device for
every patient with high-risk groin
incisions, and we expect it to become
a standard of care everywhere once
the findings are published,” he adds.
“It’s a game changer.”
In February, Megan Lundgren, MD,
a third-year General Surgery resident
and Sidney Kimmel Medical College
alumna, presented the study at the
Philadelphia Academy of Surgery’s
Annual Surgical Research Competition.
Dr. Lundgren, who helped enroll and
care for trial participants, won the
inaugural Chris Tzarnas Surgical
Research Award for the work.
Follow-up trial of new treatment
for carotid artery disease
Following the promising multi-center
ROADSTER trial, the ROADSTER 2 trial
is observing and evaluating real-world
results of a newly approved procedure
for treating carotid artery disease.
The most widely used treatment
for carotid artery disease has been
the carotid endarterectomy (CEA)
procedure, in which plaque is surgically
removed from the blocked artery.
For patients who may be at high
medical or anatomic risk for carotid
endarterectomy, carotid stenting
may be a better option. Though both
procedures are generally safe, heart
attack risk is higher with CEA, while
stroke risk is higher with stenting.
Trans-carotid Artery Revascularization
(TCAR) is designed to lower both
risks, and the initial ROADSTER trial
demonstrated its success.

“The TCAR procedure is a hybrid
of the other two treatments,” Dr.
DiMuzio says. “It places a carotid
stent through a minimally invasive
incision in the carotid artery at the
level of the neck. Blood flow in
the artery is temporarily reversed
to protect the brain from plaque
fragments that may come loose
during the procedure. A stent is then
inserted into the blood vessel to
support the artery walls and prevent
blockage or collapse.” Dr. DiMuzio
adds that stent deployment via access
directly through the common carotid
artery avoids the need to traverse the
aortic arch with catheters, which can
lead to embolic stroke.
Though approved by the FDA,
the TCAR procedure will not be
marketed until the ROADSTER 2 trial
is completed. To date, Jefferson is
the first and only study location in
the Philadelphia area. Dr. DiMuzio
and his team have already performed
the TCAR procedure and are actively
enrolling more patients.
“Nationally, the study is more than
halfway to completion — and the
TCAR procedure is on its way to
becoming an exciting new standard
of care for carotid artery disease,”
he says.
For more information, contact
the Jefferson Vascular Center
at 215-955-8304 or visit
Jefferson.edu/JVC.

Since joining the Department of Surgery
in 2001 as an administrative assistant in
the Division of Transplant Surgery, Andrea
DelMastro has moved to our 1300 Wolf Street
Office on the Methodist Campus. Born and
raised in South Philly, she has returned and
served as the Department’s practice manager
there for the past five years.
At Methodist, Andrea oversees day-to-day
operations of 14 providers and a team of
registrars, medical assistants and nurse
practitioners. The practice includes several
specialties within the Department of Surgery:
Bariatric, Breast, Colorectal, General, Thoracic
and Vascular Surgery & Vascular Medicine.
The services provided there include more than
just surgical consultations, as several other
outpatient services are offered, including
vascular ultrasound, minimally invasive vein
closure, and wound care.
During the last few years she has been
active at both campuses taking on a number
of departmental projects: she is currently
the Department’s lead for the JeffConnect
telehealth program and serves as a ‘super
user’ for the EPIC Electronic Health Record
implementation.
Another of DelMastro’s long-term projects
is contributing to the Methodist Hospital
Division’s Surgery White Paper. The purpose
of the ongoing initiative: to identify ways to
improve both patient experience and overall
surgical patient throughput at Methodist.
To date, such improvements have included
adding a room for private family surgical
consultations and staffing a patient registrar.
She appreciates the diverse challenges of
her work: “Every day is different,” she says.
“I juggle clinic hours, department projects, as
well as the unique needs of staff and patients
that come up daily.” DelMastro strives to
make sure her employees are engaged, as
she believes that “makes all the difference
in patient care.”
Above all, Andrea values being part of the
Methodist community: “I love that I get to
work in an office where I know the majority
of my patients from the neighborhood. It’s
world-class care – with a real hometown feel.”
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